MEDIGEN INC has a total of 25 patent applications. It decreased the IP activity by 80.0%. Its first patent ever was published in 2009. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are PALESE PETER, TECHNOVAX INC and IMMUNICUM AB.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 5 | |
#2 | United States | 5 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | Brazil | 2 | |
#5 | China | 2 | |
#6 | Hong Kong | 2 | |
#7 | Republic of Korea | 2 | |
#8 | Canada | 1 | |
#9 | Japan | 1 | |
#10 | Mexico | 1 | |
#11 | Peru | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides | |
#5 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Pushko Peter | 21 |
#2 | Tretyakova Irina | 15 |
#3 | Lukashevich Igor | 8 |
#4 | Irina Tretyakova | 3 |
#5 | Peter Pushko | 3 |
#6 | Igor Lukashevich | 1 |
#7 | Peter M Pushko | 1 |
Publication | Filing date | Title |
---|---|---|
CN110088273A | For the vaccine of infectious diseases caused by just strand rna virus | |
CN108348596A | With the recombinant virus sample particle of bovine immunodeficiency virus Gag albumen | |
EP2519266A2 | Infectious dna vaccines against chikungunya virus | |
WO2010008576A2 | Idna vaccines and methods for using the same |